Randomized control trial of blant-TAE with embosphere or gelpart for large hepatocellular carcinoma
Not Applicable
Recruiting
- Conditions
- hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000026838
- Lead Sponsor
- Kitasato University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Not provided
Exclusion Criteria
1)Invasion of main portal vein (Vp3, Vp4) or inferior vena cava. 2)Hepatic encephalopathy or refractory ascites. 3)Allergy to contrast media. 4)Pregnant, possibly pregnant. 5)Patients who are not suitable to be participated due to medical reason evaluated by primary physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate(4 weeks)
- Secondary Outcome Measures
Name Time Method Tumor contraction rate. Time to progression. Safety. Overall survival rate.